BE858003A - Compositions pharmaceutiques a base d'alginate de sodium - Google Patents

Compositions pharmaceutiques a base d'alginate de sodium

Info

Publication number
BE858003A
BE858003A BE180345A BE180345A BE858003A BE 858003 A BE858003 A BE 858003A BE 180345 A BE180345 A BE 180345A BE 180345 A BE180345 A BE 180345A BE 858003 A BE858003 A BE 858003A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
sodium alginate
compositions based
alginate
sodium
Prior art date
Application number
BE180345A
Other languages
English (en)
French (fr)
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of BE858003A publication Critical patent/BE858003A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE180345A 1976-11-09 1977-08-22 Compositions pharmaceutiques a base d'alginate de sodium BE858003A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB46543/76A GB1524740A (en) 1976-11-09 1976-11-09 Pharmaceutical compositions for use in the suppression of gastric reflux

Publications (1)

Publication Number Publication Date
BE858003A true BE858003A (fr) 1977-12-16

Family

ID=10441659

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180345A BE858003A (fr) 1976-11-09 1977-08-22 Compositions pharmaceutiques a base d'alginate de sodium

Country Status (15)

Country Link
US (1) US4140760A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5359016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU509823B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE858003A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1083964A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2738014A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2369843A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1524740A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK59681A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE45655B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KE (1) KE3175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL188892C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ184931A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA774920B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
GB8323624D0 (en) * 1983-09-02 1983-10-05 Reckitt & Colmann Prod Ltd Medicinal compositions
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
EP0179858B1 (en) * 1984-04-19 1992-07-01 Rhone-Poulenc Rorer International (Holdings) Inc. Antacid composition
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
WO1987004077A1 (en) * 1986-01-03 1987-07-16 The University Of Melbourne Gastro-oesophageal reflux composition
US5254591A (en) * 1986-01-03 1993-10-19 The University Of Melbourne Pharmaceutical composition for treating gastroesophageal reflux
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
US5112813A (en) * 1986-03-07 1992-05-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Process for the preparation of a viscosity-stable antacid composition
US5002777A (en) * 1986-06-24 1991-03-26 Norcliff Thayer Inc. Encapsulated antacid
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
IE60726B1 (en) * 1988-09-20 1994-08-10 Glaxo Group Ltd Pharmaceutical compositions
US5460803A (en) * 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5827247A (en) * 1991-08-20 1998-10-27 Bioderm External incontinence device and vapor-absorptive adhesive compositions
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
US5427768A (en) * 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
CA2288743C (en) * 1997-04-30 2008-04-22 Reckitt & Colman Products Limited Pourable alginate compositions
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
CA2323212A1 (en) * 1998-03-11 1999-09-16 Smithkline Beecham Corporation Process of making an aqueous calcium carbonate suspension
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US20030165606A1 (en) * 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
SE0103722D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
SE0103613D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
US6779530B2 (en) * 2002-01-23 2004-08-24 Schweitzer-Mauduit International, Inc. Smoking articles with reduced ignition proclivity characteristics
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
DE102004063612B4 (de) * 2004-01-02 2017-01-12 Manfred Helms Gelartiges Basenpräparat sowie Verwendung eines Gelbildners zu dessen Herstellung
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US8151806B2 (en) * 2005-02-07 2012-04-10 Schweitzer-Mauduit International, Inc. Smoking articles having reduced analyte levels and process for making same
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
SE530605C2 (sv) * 2005-09-29 2008-07-15 Barbara Nelson Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar
US20070087038A1 (en) * 2005-10-05 2007-04-19 Fmc Biopolymer As Gelling compositions and methods
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
WO2007143101A2 (en) * 2006-06-01 2007-12-13 Schweitzer-Mauduit International, Inc. Free air burning smoking articles with reduced ignitiion proclivity characteristics
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090148530A1 (en) 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
EP2560732A2 (en) * 2010-04-23 2013-02-27 S-Biotek Holding ApS A solid pharmaceutical composition for neutralizing stomach acid
LT2806880T (lt) 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
RU2479318C1 (ru) * 2012-03-29 2013-04-20 Общество с ограниченной ответственностью "ВИТТА" (ООО "ВИТТА") Способ получения лекарственных и биологически активных средств
KR101417287B1 (ko) * 2012-06-15 2014-07-08 동아제약 주식회사 신규한 위식도역류질환 치료용 조성물
DE112013003596T5 (de) * 2012-07-19 2015-04-09 Relypsa, Inc. Zusammensetzungen, umfassend vernetzte kationbindende Polymere und deren Verwendung
JP5939943B2 (ja) 2012-09-14 2016-06-22 ヤンマー株式会社 エンジン装置
CN104797147B (zh) 2012-10-11 2019-08-13 施韦特-莫迪国际公司 具有降低引燃倾向特性的包装材料
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법
ITUB20159732A1 (it) * 2015-12-22 2017-06-22 S I I T S R L Servizio Int Imballaggi Termosaldanti Composizioni orali per il trattamento della malattia da reflusso gastroesofageo
FR3071728B1 (fr) 2017-09-29 2019-09-27 Laboratoires Arkopharma Composition adaptee pour former un radeau gastrique gelifie
IL277016B2 (en) * 2018-03-02 2025-01-01 Pharagen Llc Acid reflux treatment formulations that include sodium alginate
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
WO2019223753A1 (zh) 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法
CN115777783A (zh) * 2022-07-04 2023-03-14 浙江上方生物科技有限公司 一种防止胃食管倒流的健康饮料及其制备方法
JP2025525127A (ja) 2022-08-02 2025-08-01 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー 抗逆流液体製剤の新規なアルギン酸塩及びセルロース誘導体ベースの組成物
WO2024030936A1 (en) * 2022-08-02 2024-02-08 Nutrition & Biosciences Usa 1, Llc Modified-release alginate-based composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330729A (en) * 1963-10-04 1967-07-11 Goodrich Co B F Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
US3326755A (en) * 1965-06-15 1967-06-20 Warner Lambert Pharmaceutical Alginate containing antacid compositions
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
JPS5176415A (en) * 1974-12-26 1976-07-02 Riken Vitamin Oil Co Ltd Choyoseiseizaino seizohoho

Also Published As

Publication number Publication date
IE45655L (en) 1978-05-09
JPS646172B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-02
KE3175A (en) 1982-01-08
CY1131A (en) 1982-05-07
FR2369843A1 (fr) 1978-06-02
DE2738014A1 (de) 1978-05-18
GB1524740A (en) 1978-09-13
CA1083964A (en) 1980-08-19
AU509823B2 (en) 1980-05-29
DE2738014C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-08-18
IE45655B1 (en) 1982-10-20
JPS5359016A (en) 1978-05-27
ZA774920B (en) 1979-03-28
NZ184931A (en) 1979-06-08
HK59681A (en) 1981-12-11
NL7709307A (nl) 1978-05-11
FR2369843B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-12-26
AU2830677A (en) 1979-03-08
NL188892C (nl) 1992-11-02
US4140760A (en) 1979-02-20

Similar Documents

Publication Publication Date Title
BE858003A (fr) Compositions pharmaceutiques a base d'alginate de sodium
BE858522A (fr) Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
LU90153I2 (fr) Modiodal 100 mg
FR2385164B1 (fr) Panneau d'affichage
BR7903853A (pt) Composicoes herbicidas a base de derivados de pirazol
PT66622A (en) Pharmaceutical compositions
AU3111677A (en) Pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
SE7711395L (sv) Farmaceutisk komposition
FR2334365A1 (fr) Preparation a base de diethylaminoethyl-dextrane inhibant l'absorption des lipides
BR7900964A (pt) Composicoes herbicidas a base de derivados de piridazona
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
IT1094178B (it) Composizioni a base d'argento
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
NZ186147A (en) Sterolin pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
BE873481A (fr) Nouvelles compositions pharmaceutiques a base de prostaglandines
AU2609277A (en) Pharmaceutical compositions
BE879786A (fr) Nouvelles compositions pharmaceutiques a base d'aryltrifluoro-ethanol
FR2323397A1 (fr) Composition medicinale a base d'hormones
BE863137A (fr) Compositions pharmaceutiques a base d'acides alpha-mercapto-beta-arylacryliques
BE863723A (fr) Nouvelles compositions pharmaceutiques a base de chlorhexidine
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
SE7705658L (sv) Farmaceutisk komposition
GB1547206A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: RECKITT AND COLMAN PRODUCTS LTD

Effective date: 19970822